Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to ensure that people with atrial fibrillation at high risk of stroke receive anticoagulation medication; and whether this will be reflected in the metrics accompanying the cardiovascular disease modern service framework.

CVDPREVENT data indicates that approximately 90% of patients with general practice recorded atrial fibrillation are currently treated with a direct oral anticoagulant or vitamin K antagonist. One of the objectives included in the Cardiovascular Disease Modern Service Framework (CVD MSF) is to maintain and maximise that activity, and we will report performance against that objective on a regular basis, alongside other CVD MSF priorities.